Copyright
©The Author(s) 2024.
World J Clin Cases. Jan 26, 2024; 12(3): 503-516
Published online Jan 26, 2024. doi: 10.12998/wjcc.v12.i3.503
Published online Jan 26, 2024. doi: 10.12998/wjcc.v12.i3.503
Table 4 Identified exonic variants in the first consanguineous family
Gene (gene) | SHPRH | SLC30A9 | HBS1L | TAAR6 | TAAR2 | SASH1 | LOC100287896 | PCF11 | ANKRD42 | PDGFD | DIXDC1 |
Chromosome | 6 | 4 | 6 | 6 | 6 | 6 | 11 | 11 | 11 | 11 | 11 |
Location (varLocation) | Exonic | Intronic | intronic | Exonic | Exonic | Exonic | Exonic | Exotic | Exonic | Exonic | Exonic |
Effect (codingEffect) | Nonsynonymous | Nonsynonymous | Nonsynonymous | Nonsynonymous | Nonsynonymous | Nonsynonymous | Nonsynonymous | Nonsynonymous | Nonsynonymous | ||
cDNA (cNomen) | c.4331C>T | c.528-7T>C | c.2043+5T>G | c.865C>T | c.467C>T | c.1126C>T | c.4C>T | c.3355C>T | c.676A>G | c.7C>G | c.226G>A |
Protein (pNomen) | p.A1444V | p.P289S | p.T156I | p.P376S | p.R2C | p.H1119Y [Histidine (His)- Tyrosine (Tyr)] | p.N226D [Asparagine (Asn)- Aspartic Acid (Asp)] | p.R3G [Arginine (Arg)- Glycine (Gly)] | p.G76S [Glycine (Gly)- Serine (Ser)] | ||
Pathogenicity | 09/11 | This mutation probably has no impact on splicing | Activation of an intronic cryptic donor site. | 07/11 | 10/11 | 09/11 | 08/11 | 09/11 | 03/Nov | 0/11 | |
Potential alteration of splicing | |||||||||||
GME Variome (%) | Not available | Not available | Not available | 0.1 | Not available | Not available | Not available | 0.1 | 0.1 | 0.1 | Not available |
Gnomad browser (%) | 0.0008 | 0.04 | 0.2 | 0.006 | 0.001 | 0.001 | 0.4 | 0.2 | 0.3 | 0.01 | 0.002 |
- Citation: Manoubi W, Mahdouani M, Hmida D, Kdissa A, Rouissi A, Turki I, Gueddiche N, Soyah N, Saad A, Bouwkamp C, Elgersma Y, Mougou-Zerelli S, Gribaa M. Genetic investigation of the ubiquitin-protein ligase E3A gene as putative target in Angelman syndrome. World J Clin Cases 2024; 12(3): 503-516
- URL: https://www.wjgnet.com/2307-8960/full/v12/i3/503.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i3.503